Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SCVX
Washington, Washington, D.C., United States
- Ownership
- Public · SCV
- Development stage
- Other
01
Overview
SCVX Corp. was a special purpose acquisition company (SPAC) formed for the purpose of effecting a merger, share exchange, asset acquisition, or similar business combination with one or more businesses. While the company initially focused its search on the cybersecurity sector, it was frequently evaluated by analysts within the broader technology and data-driven healthcare sectors. The company was led by Mike Doniger and Hank Thomas, the latter being a co-founder of Strategic Cyber Ventures. SCVX went public in early 2020 but ultimately failed to complete a business combination within its allotted timeframe. Consequently, the company liquidated its assets and redeemed its public shares in 2022.
- Industry
- Investors
Beyond the preview
Go deeper on SCVX.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SCVX.